Adlisa SRL
Adlisa reported total assets of 929,195 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Adlisa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -71 % Total assets +88 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Adlisa's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 77,206 € | ||||
| Equity | 88,877 € | ||||
| Cash | 79,871 € | ||||
| EBITDA | 168,707 € | ||||
| Total assets | 929,195 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Adlisa's financial analysis
- Solvency9.6%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Adlisa
Adlisa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0741.739.402
- VAT number
- BE0741739402
- Peppol
- Registered · 0208:0741739402 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2020
- Registered office
- 1331 Rixensart
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Adlisa (SRL) has been based in Rixensart since 2020, active in: manufacture of medicaments. For 2025, it reports a net profit of 77,206 € and equity of 88,877 €; its revenue is not published. Its solvency stands at 9.6%, below the median of its sector (34.4%).
Companies similar to Adlisa
Companies in the same business, of comparable size and area, outside its group.
- Dokter Eric Germonpre Medical specialists activities Ghent · balance sheet 929,267 €
- DR Sina Behrouz medecin -cardiologue Brussels · balance sheet 878,228 €
- Docteur Philippart - Chirurgie Digestive ET Oncologie Ath · balance sheet 929,094 €
- DR.Alain Lefevre Medical specialists activities La Louvière · balance sheet 929,441 €
- Cools EN CO Antwerp · balance sheet 929,650 €
- Oudoumont Verlaine · balance sheet 928,621 €
- Cabinet DE Medecine Generale Jean-Claude Fafchamps Étalle · balance sheet 929,798 €
- Bavenco Rental and operating of own or leased real estate Sint-Niklaas · balance sheet 929,815 €
Frequently asked questions about Adlisa
What is the revenue of Adlisa?
Adlisa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Adlisa?
In Belgium, the VAT number is the company number prefixed with BE: BE0741739402 for Adlisa, if the company is VAT-registered. Its company number (CBE) is 0741.739.402.
Where is the registered office of Adlisa?
According to the CBE register, the registered office of Adlisa is in 1331 Rixensart.
What is the equity of Adlisa?
At the close of the 2025 financial year, the equity of Adlisa amounts to 88,877 €, a solvency of 9.6% of total assets.
Who manages Adlisa?
The register lists 1 active mandates at Adlisa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Adlisa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →